Company Filing History:
Years Active: 1987
Title: Douglas E Ewing: Innovator in Neuropsychiatric Treatment
Introduction
Douglas E Ewing is a notable inventor based in Augusta, GA (US). He has made significant contributions to the field of neuropsychiatric disorders through his innovative research and patent work. His dedication to advancing medical treatments has positioned him as a key figure in his area of expertise.
Latest Patents
Ewing holds a patent for the use of 3-N-phenylacetylamino-2,6-piperidinedione for treatment. This composition is disclosed as useful in the treatment of neuropsychiatric disorders involving monoamine oxidase regulation. The compound has been shown to be an effective and selective MAO type B inhibitor, showcasing its potential in therapeutic applications.
Career Highlights
Ewing's career is marked by his work at Stereochemical Genetics, Inc., where he has focused on developing innovative solutions for complex medical challenges. His research has contributed to a deeper understanding of neuropsychiatric conditions and their treatment.
Collaborations
Ewing has collaborated with notable colleagues, including Lawrence B Hendry and Ana H Diamond. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic approaches.
Conclusion
Douglas E Ewing's contributions to the field of neuropsychiatric treatment through his patent and collaborative efforts highlight his commitment to innovation in medicine. His work continues to pave the way for advancements in the treatment of mental health disorders.